Other potential approaches have been reported such as the adenoviral delivery of TRAIL coding sequence into tumor cells [33–34] or the more “drug-like” synthetic multivalent ligands of DR5 (TRAILmim/DR5)[22]. This evidence concerns the gene TNFRSF10B and neoplasm.